Cell Therapy Market Report (2021-2031) | The Insight Partners
细胞治疗市场规模预计将从 2023 年的 95.9 亿美元增至 2031 年的 167.2 亿美元。预计 2023-2031 年期间,该市场的复合年增长率将达到 7.2%。细胞疗法的进步和主要制造商推出的新产品可能仍是细胞治疗市场的主要趋势。
细胞治疗市场分析
再生疗法诱导细胞、组织和器官再生,然后帮助恢复其功能。根据再生医学联盟的数据,截至 2023 年第四季度,全球正在进行 520 项利用细胞疗法药物的临床试验(192 项 I 期、125 项 II 期、36 项 III 期)。此外,2017 年首个此类细胞疗法 Kymriah 的批准和商业化是细胞疗法在细胞和基因治疗领域继续占据重要地位的重要事件(C>)。CAR-T 细胞(即嵌合抗原受体 T 细胞)疗法的发展改变了某些癌症的治疗方法。CAR-T 细胞疗法一直是全球研究和创新最多的主题;基于该技术的另外五种产品,即 Yescarta、Abecma、Tecartus、Breyanzi 和 Carvykti,已获批用于治疗各种血癌。因此,再生医学应用范围的不断扩大推动了细胞治疗市场的增长。
细胞治疗市场概览
CAR-T 细胞疗法已被证明是一种很有前途的癌症治疗方法。每年都有大量的临床前和临床试验来研究其在较新的治疗应用中的用途。除了自体和同种异体产品外,新的体内 CAR-T 细胞基因疗法及其在血液系统恶性肿瘤以外的适应症中的疗效很可能成为未来研究的主要重点。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
细胞治疗市场:
复合年增长率(2023 - 2031)7.2%- 2023 年市场规模
95.9 亿美元 - 2031年市场规模
167.2亿美元
市场动态
- 治疗癌症等慢性疾病的新型疗法需求增加
- 技术进步
- 研发资金
关键人物;主力;重要一员
- Vericel 公司 Corporation
- 医疗邮政
- NuVasive 公司 Inc
- 美索宝有限公司 Limited
- JCR制药有限公司
- 施乐辉
- 百时美施贵宝公司
- 细胞对细胞
- Stemedica细胞技术公司
- Castle Creek 生物科学公司
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 同种异体和自体
- 耗材和设备
- 系统和软件
- 病毒载体技术
- 基因组编辑技术
- 体细胞技术
- 细胞永生化技术
- 细胞可塑性技术
- 三维技术
- 肿瘤学
- 心血管
- 骨科
- 伤口处理
- 其他应用
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
细胞治疗市场驱动因素和机遇
癌症发病率上升有利于市场增长
久坐不动的生活方式、饮食习惯的改变等是导致神经系统疾病、癌症、自身免疫性疾病和心血管疾病等突出慢性疾病的众所周知的危险因素。根据美国疾病控制和预防中心的数据,每 10 个美国人中就有 6 个患有一种或多种慢性疾病,包括糖尿病、癌症、心脏病或中风。慢性病是美国死亡和残疾的主要原因之一。遗传易感性、加工食品、污染和生活方式的改变是导致癌症患病率飙升的因素。根据美国癌症协会的数据,2020 年全球新增癌症病例近 1930 万例。细胞疗法已成为过去几十年来一种新的癌症治疗方法。T 细胞在实验室环境中进行修改,然后注入体内以靶向癌细胞。CAR-T 细胞疗法用于治疗成人和儿童白血病病例以及几种类型的淋巴瘤。此外,它正在被研究作为其他癌症疾病的潜在治疗方法,包括胸部实体瘤。因此,癌症患者数量的增加推动了对CAR-T细胞疗法的需求,从而促进了细胞疗法市场的增长。
研发资金
由于在接受过治疗的复发/难治性恶性肿瘤患者中观察到了完全缓解率和无进展生存期,研究人员有动力研究提高细胞疗法有效性的方法。研究人员正在研究抗原丢失等可能导致免疫逃逸的因素,并想出应对方法。设计细胞疗法以同时针对多种抗原是一种有益的方法。世界上最大的再生医学组织加州再生医学研究所 (CIRM) 已拨款 4380 万美元,用于支持加州基因治疗和干细胞研究的计划。该奖项支持该研究所的临床、发现和基础设施计划中的项目。
细胞治疗市场报告细分分析
有助于细胞治疗市场分析的关键部分是治疗类型、产品、技术、应用和最终用户。
- 根据治疗类型,细胞治疗市场分为同种异体和自体。同种异体部分在 2023 年占据了更大的市场份额。
- 按产品划分,市场分为消耗品、设备、系统和软件。设备部分在 2023 年占据了最大的市场份额。
- 从技术角度来看,市场分为病毒载体技术、基因组编辑技术、体细胞技术、细胞永生化技术、细胞可塑性技术、三维技术等。
- 根据应用,市场细分为肿瘤科、心血管科、骨科、伤口管理和其他应用。2023 年,肿瘤科占据了最大的市场份额。
- 根据最终用户,细胞治疗市场分为研究机构、医院和其他。医院部门在 2023 年占据了最大的市场份额。
细胞治疗市场份额按地区分析
细胞治疗市场报告的地理范围分为五个区域:北美、亚太地区、欧洲、中东和非洲以及南美和中美洲。北美占据市场主导地位。在北美,美国在 2023 年占据了细胞治疗市场的最大份额。市场增长归因于研发的增加,以及干细胞、基因和免疫疗法等细胞疗法的采用激增。遗传和细胞疾病发病率的上升,以及对扩大细胞疗法开发和制造能力的日益关注,进一步有利于细胞治疗市场的进步。拜耳公司在伯克利建立了其首个细胞疗法启动设施,以便为全球患者提供细胞疗法。该设施耗资 2.5 亿美元,占地 100,000 平方英尺,将提供后期临床试验所需的材料,以促进 bemdaneprocel (BRT-DA01) 的商业化推出,这是一种实验性细胞疗法,正在由 BlueRock Therapeutics 测试,用于治疗帕金森病和其他疾病。预计预测期内亚太地区细胞治疗市场复合年增长率最高。
细胞治疗市场报告范围
报告属性 | 细节 |
---|---|
2023 年的市场规模 | 95.9亿美元 |
2031 年市场规模 | 167.2亿美元 |
全球复合年增长率(2023 - 2031) | 7.2% |
历史数据 | 2021-2022 |
预测期 | 2023-2031 |
涵盖的领域 | 按治疗类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
细胞治疗市场新闻和最新发展
细胞治疗市场通过收集一级和二级研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下列出了细胞治疗市场的一些发展情况:
- Ginkgo Bioworks 是一家致力于构建细胞编程和生物安全领先平台的公司,该公司宣布收购 Modulus Therapeutics 的细胞治疗平台资产,包括其 CAR 和开关受体库。(来源:Ginkgo Bioworks 公司名称,新闻稿,2024 年)
- 阿斯利康签署最终协议,收购 Gracell Biotechnologies Inc.,后者是一家全球临床阶段生物制药公司,致力于开发用于治疗癌症和自身免疫性疾病的创新细胞疗法。(来源:阿斯利康公司名称,新闻稿,2024 年)
细胞治疗市场报告覆盖范围和交付成果
“细胞治疗市场规模和预测(2021-2031)”报告对以下领域进行了详细的市场分析:
- 范围内涵盖的所有主要细分市场的全球、区域和国家层面的细胞治疗市场规模和预测
- 细胞治疗市场趋势以及市场动态,如驱动因素、限制因素和关键机遇
- 详细的 PEST/波特五力分析和 SWOT 分析
- 细胞治疗市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
- 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及细胞治疗市场的最新发展
- 详细的公司简介
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.